Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01770665 · ClinicalTrials.gov registry record
Validation of the MiCK Assay
A clinical trial, sponsored by Pierian Biosciences.
- Terminated
- Registry status
- 21
- Enrollment target
NCT01770665: Clinical Trial study, sponsored by Pierian Biosciences.
NCT01770665 is a clinical trial that was terminated before completion, run by Pierian Biosciences. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01770665 was terminated before completion, sponsored by Pierian Biosciences.
- TERMINATED
- Registry status
- 21 participants
- Enrollment target
Study Summary
Testing Mayo Clinic cancer patients with the results being correlated with prior patient therapy, performance status, and extent of disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2012-06 |
| Est. Completion | 2016-09 |
Why NCT01770665 stopped before completion
NCT01770665 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 21 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01770665 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01770665 about?
NCT01770665 is a clinical study titled "Validation of the MiCK Assay". Testing Mayo Clinic cancer patients with the results being correlated with prior patient therapy, performance status, and extent of disease.
What is the current status of trial NCT01770665?
This trial is currently terminated. The enrollment target is 21 participants. The study started on 2012-06. Estimated completion is 2016-09.
Who is sponsoring clinical trial NCT01770665?
This trial is sponsored by Pierian Biosciences, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia